Douglas S. Ingram
CIK: 0001190644
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 9, 2026RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
32.9K shares- - Dec 16, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Award(A)Direct7.8K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct73K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct96.5K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct50K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct269.5K shares- - Dec 7, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct50K shares- - Jun 6, 2025RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
136.7K shares- - Feb 6, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Award(A)Direct38.4K shares at avg. $20.09$771K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 32,947 | - | - | Direct |
| Dec 16, 2025 |  ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award(A) | 7,819 | - | - | Direct |
| Dec 7, 2025 |  SRPT Sarepta Therapeutics, Inc. | Award(A) | 73,001 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 96,541 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 50,000 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 269,542 | - | - | Direct |
| Dec 7, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 50,000 | - | - | Direct |
| Jun 6, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 136,681 | - | - | Direct |
| Feb 6, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award(A) | 38,396 | $20.09 | $771,376 | Direct |
1-9 of 9 transactions
About INGRAM DOUGLAS S
INGRAM DOUGLAS S (SEC CIK 0001190644) files insider reports with the SEC as Director of Relay Therapeutics, Inc. (RLAY), Director of ARROWHEAD PHARMACEUTICALS, INC. (ARWR) and Chief Executive Officer of Sarepta Therapeutics, Inc. (SRPT).
Signal8 holds 6 ownership filings by INGRAM DOUGLAS S (1 Form 3, 5 Form 4), filed between Feb 7, 2025 and Jun 10, 2026. Those filings report 9 transactions, from Feb 6, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on INGRAM DOUGLAS S's filings is in CAMBRIDGE, MA.
Recent filings by INGRAM DOUGLAS S
- Jun 9, 2026: Grant or award of RLAY derivative securities (Form 4, code A).
- Dec 16, 2025: Grant or award of ARWR shares (Form 4, code A).
- Dec 7, 2025: Grants or awards of SRPT shares (5 lines, Form 4, code A).
- Jun 6, 2025: Grant or award of RLAY derivative securities (Form 4, code A).
- Feb 6, 2025: Grant or award of ARWR shares (Form 4, code A).
Other insiders filing for Relay Therapeutics, Inc. (RLAY)
- Rahmer Peter
- Bergstrom Donald A, President, R&D
- Catinazzo Thomas, Chief Financial Officer
- Patel Sanjiv, President and CEO
- SVF Pauling (Cayman) Ltd, 10% Owner
- Mazumdar Claire, Director